Cargando…

Effects of Metoclopramide on Feeding Intolerance among Preterm Neonates; A Randomized Controlled Trial

Objective: To evaluate the efficacy and safety of metoclopramide in the treatment of feeding intolerance in preterm neonates less than 36 weeks of gestational age. Methods: A randomized, controlled, masked cross-over study. A block of 4 randomizations was used. The “drug group” received intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Mussavi, Mirhadi, Asadollahi, Khairollah, Abangah, Ghobad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359419/
https://www.ncbi.nlm.nih.gov/pubmed/25793073
_version_ 1782361402446446592
author Mussavi, Mirhadi
Asadollahi, Khairollah
Abangah, Ghobad
author_facet Mussavi, Mirhadi
Asadollahi, Khairollah
Abangah, Ghobad
author_sort Mussavi, Mirhadi
collection PubMed
description Objective: To evaluate the efficacy and safety of metoclopramide in the treatment of feeding intolerance in preterm neonates less than 36 weeks of gestational age. Methods: A randomized, controlled, masked cross-over study. A block of 4 randomizations was used. The “drug group” received intravenous metoclopramide before feeding and placebo group received placebo at the same time. The time to full enteral feeding and suspected adverse effects of metoclopramide, length of hospital stay or incidence of NEC or septicemia were the main outcome measures. Findings: Mean (standard deviation) of weight and Apgar score among metoclopramide and placebo groups were 1638.3±321 gr, 8.9±1.4 and 1593.3±318.8 gr, 8.8±1.3 respectively. Times to full feeding were significantly shorter in the metoclopramide group than in the control group (12.9±5.6 vs 17.0±6.3; P<0.0001) and also the numbers of withheld feedings were significantly lower (P<0.0001). According to the regression analysis, lower weight and placebo group were significantly related to increasing of lavage frequency, number of vomits, start time of feeding, number of feeding cessations and decreased feeding completion time (P<0.0001).No adverse effects of this treatment modality were observed in the two groups. Conclusion: Intravenous metoclopramide may be considered as an attempt in facilitating and treatment of feeding intolerance in preterm neonates.
format Online
Article
Text
id pubmed-4359419
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-43594192015-03-19 Effects of Metoclopramide on Feeding Intolerance among Preterm Neonates; A Randomized Controlled Trial Mussavi, Mirhadi Asadollahi, Khairollah Abangah, Ghobad Iran J Pediatr Original Article Objective: To evaluate the efficacy and safety of metoclopramide in the treatment of feeding intolerance in preterm neonates less than 36 weeks of gestational age. Methods: A randomized, controlled, masked cross-over study. A block of 4 randomizations was used. The “drug group” received intravenous metoclopramide before feeding and placebo group received placebo at the same time. The time to full enteral feeding and suspected adverse effects of metoclopramide, length of hospital stay or incidence of NEC or septicemia were the main outcome measures. Findings: Mean (standard deviation) of weight and Apgar score among metoclopramide and placebo groups were 1638.3±321 gr, 8.9±1.4 and 1593.3±318.8 gr, 8.8±1.3 respectively. Times to full feeding were significantly shorter in the metoclopramide group than in the control group (12.9±5.6 vs 17.0±6.3; P<0.0001) and also the numbers of withheld feedings were significantly lower (P<0.0001). According to the regression analysis, lower weight and placebo group were significantly related to increasing of lavage frequency, number of vomits, start time of feeding, number of feeding cessations and decreased feeding completion time (P<0.0001).No adverse effects of this treatment modality were observed in the two groups. Conclusion: Intravenous metoclopramide may be considered as an attempt in facilitating and treatment of feeding intolerance in preterm neonates. Tehran University of Medical Sciences 2014-10 2014-10-28 /pmc/articles/PMC4359419/ /pubmed/25793073 Text en Copyright © 2014 by Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, All rights reserved This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mussavi, Mirhadi
Asadollahi, Khairollah
Abangah, Ghobad
Effects of Metoclopramide on Feeding Intolerance among Preterm Neonates; A Randomized Controlled Trial
title Effects of Metoclopramide on Feeding Intolerance among Preterm Neonates; A Randomized Controlled Trial
title_full Effects of Metoclopramide on Feeding Intolerance among Preterm Neonates; A Randomized Controlled Trial
title_fullStr Effects of Metoclopramide on Feeding Intolerance among Preterm Neonates; A Randomized Controlled Trial
title_full_unstemmed Effects of Metoclopramide on Feeding Intolerance among Preterm Neonates; A Randomized Controlled Trial
title_short Effects of Metoclopramide on Feeding Intolerance among Preterm Neonates; A Randomized Controlled Trial
title_sort effects of metoclopramide on feeding intolerance among preterm neonates; a randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359419/
https://www.ncbi.nlm.nih.gov/pubmed/25793073
work_keys_str_mv AT mussavimirhadi effectsofmetoclopramideonfeedingintoleranceamongpretermneonatesarandomizedcontrolledtrial
AT asadollahikhairollah effectsofmetoclopramideonfeedingintoleranceamongpretermneonatesarandomizedcontrolledtrial
AT abangahghobad effectsofmetoclopramideonfeedingintoleranceamongpretermneonatesarandomizedcontrolledtrial